You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
Neonatal dexamethasone treatment exacerbates hypoxic-ischemic brain injury
|
---|---|
Published in |
Molecular Brain, April 2013
|
DOI | 10.1186/1756-6606-6-18 |
Pubmed ID | |
Authors |
Kan-Hsun Chang, Che-Ming Yeh, Chia-Yu Yeh, Chiung-Chun Huang, Kuei-Sen Hsu |
Abstract |
The synthetic glucocorticoid dexamethasone (DEX) is commonly used to prevent chronic lung disease in prematurely born infants. Treatment regimens usually consist of high doses of DEX for several weeks, notably during a critical period of brain development. Therefore, there is some concern about adverse effects of this clinical practice on fetal brain development. In this study, using a clinically relevant rat model, we examined the impact of neonatal DEX treatment on subsequent brain injury due to an episode of cerebral hypoxia-ischemia (HI). |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 3% |
Spain | 1 | 3% |
United States | 1 | 3% |
Egypt | 1 | 3% |
Unknown | 32 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 22% |
Researcher | 7 | 19% |
Student > Master | 6 | 17% |
Student > Bachelor | 2 | 6% |
Lecturer | 2 | 6% |
Other | 7 | 19% |
Unknown | 4 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 22% |
Agricultural and Biological Sciences | 8 | 22% |
Neuroscience | 8 | 22% |
Psychology | 2 | 6% |
Nursing and Health Professions | 1 | 3% |
Other | 4 | 11% |
Unknown | 5 | 14% |